ClinicalTrials.Veeva

Menu

PEDI-REAVASC Resonance Imaging of Infants With Hypoxic Ischemic Encephalopathy After Hypothermia Treatment.

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Active, not recruiting

Conditions

Encephalopathy, Hypoxic-Ischemic

Treatments

Diagnostic Test: MRI-scan

Study type

Interventional

Funder types

Other

Identifiers

NCT06370624
2022/03OCT/360

Details and patient eligibility

About

This study is a prospective, observational, single-center study to assess the correlation between rs-fMRI measures and clinical measures of standard MRI, NIRS, EEG and clinical scores.

The target population was neonates with HIE referred to MRI after hypothermia treatment, which was initiated within 6 hours of birth, continued for 72 hours and followed by a slow rewarming period of 6-12 hours.

A one-year clinical and imaging follow-up is planned. As the aim of the present study is to assess the predictiveness of the outcome one year after the HIE event, no follow-up is planned.

Enrollment

30 estimated patients

Sex

All

Ages

1 hour to 14 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

Newborns at 36 weeks gestation or more, with HIE treated with therapeutic hypothermia will be prospectively included.

Exclusion criteria

  • Lack of parental consent
  • Congenital anomalies that make hypothermia treatment not indicated
  • Coagulopathy with active bleeding

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Newborns
Experimental group
Treatment:
Diagnostic Test: MRI-scan

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems